These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8596251)

  • 1. Excessive beta-blockade with timolol eye drops.
    Kalenak JW
    JAMA; 1996 Apr; 275(13):985; author reply 986. PubMed ID: 8596251
    [No Abstract]   [Full Text] [Related]  

  • 2. Excessive beta-blockade with timolol eye drops.
    Novack GD
    JAMA; 1996 Apr; 275(13):985; author reply 986. PubMed ID: 8596252
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops. Potential for oral-ophthalmic drug interaction.
    Edeki TI; He H; Wood AJ
    JAMA; 1995 Nov 22-29; 274(20):1611-3. PubMed ID: 7474246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of 3 topically administered beta blockers on the rabbit crystalline lens].
    Eckerskorn U; Wegener A; Hockwin O; Fournes C; Ermisch S; Müller P; Möller B
    Fortschr Ophthalmol; 1988; 85(2):139-43. PubMed ID: 2899043
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of the anti-Acanthamoeba activity of two commercial eye drops commonly used to lower eye pressure.
    Sifaoui I; Reyes-Batlle M; López-Arencibia A; Wagner C; Chiboub O; De Agustino Rodríguez J; Rocha-Cabrera P; Valladares B; Piñero JE; Lorenzo-Morales J
    Exp Parasitol; 2017 Dec; 183():117-123. PubMed ID: 28778743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical beta-adrenergic antagonists and quinidine. A risky interaction.
    Higginbotham EJ
    Arch Ophthalmol; 1996 Jun; 114(6):745-6. PubMed ID: 8639090
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of CYP2D6 single-nucleotide polymorphism with response to ophthalmic timolol in primary open-angle Glaucoma--a pilot study.
    Yuan H; Yu M; Yang Y; Wu K; Lin X; Li J
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):497-501. PubMed ID: 20925579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical timolol and lipid profile.
    Manoher JM; Sharma AK; Sahai R
    Indian J Ophthalmol; 1995 Jun; 43(2):73-4. PubMed ID: 8818314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of timolol and UF-021 (a prostaglandin-related compound) on pulsatile ocular blood flow in normal volunteers.
    Kitaya N; Yoshida A; Ishiko S; Mori F; Abiko T; Ogasawara H; Kato Y; Nagaoka T
    Ophthalmic Res; 1997; 29(3):139-44. PubMed ID: 9211466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Corneal sensitivity after single doses of timolol, betaxolol or placebo in persons with healthy eyes--a randomized, prospective double-blind study].
    Höh H
    Fortschr Ophthalmol; 1988; 85(2):132-8. PubMed ID: 2899042
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of topical nipradilol and timolol maleate on intraocular pressure, facility of outflow, arterial blood pressure and pulse rate in dogs.
    Maehara S; Ono K; Ito N; Tsuzuki K; Seno T; Yokoyama T; Yamashita K; Izumisawa Y; Kotani T
    Vet Ophthalmol; 2004; 7(3):147-50. PubMed ID: 15091320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A clinico-pharmacological study of an ophthalmic drug form of proxodolol].
    Ermakova VN
    Eksp Klin Farmakol; 1994; 57(3):57-9. PubMed ID: 7914124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case.
    Battistini FD; Tártara LI; Boiero C; Guzmán ML; Luciani-Giaccobbe LC; Palma SD; Allemandi DA; Manzo RH; Olivera ME
    Eur J Pharm Sci; 2017 Jul; 105():188-194. PubMed ID: 28506871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optic nerve vasomotor effects of topical beta-adrenergic antagonists in rabbits.
    Orgül S; Mansberger S; Bacon DR; Van Buskirk EM; Cioffi GA
    Am J Ophthalmol; 1995 Oct; 120(4):441-7. PubMed ID: 7573301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atrioventricular block secondary to topical ophthalmic beta blockers].
    Rubín López JM; Hevía Nava S; Veganzones Bayón A; Barriales Alvarez V
    Rev Esp Cardiol; 1999 Jul; 52(7):532. PubMed ID: 10439680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microemulsions with timolol as potential eye drops.
    Malina I; Radomska-Soukharev A
    Pharmazie; 2006 Jul; 61(7):650-1. PubMed ID: 16889077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoting effect of borneol on the permeability of puerarin eye drops and timolol maleate eye drops through the cornea in vitro.
    Wu CJ; Huang QW; Qi HY; Guo P; Hou SX
    Pharmazie; 2006 Sep; 61(9):783-8. PubMed ID: 17020156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A clinical study of Timolol Maleate Eye Drops for the treatment of superficial infantile hemangiomas].
    Linjun Y; Jiachuan X; Baoli S; Qixing X; Chunfen L
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Nov; 31(6):440-5. PubMed ID: 27055324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic effects of three beta-blocker eyedrops: comparison in healthy volunteers of beta 1- and beta 2-adrenoreceptor inhibition.
    Le Jeunne C; Munera Y; Hugues FC
    Clin Pharmacol Ther; 1990 May; 47(5):578-83. PubMed ID: 1971539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergic contact dermatitis from timolol and dorzolamide eye drops.
    Kalavala M; Statham BN
    Contact Dermatitis; 2006 Jun; 54(6):345. PubMed ID: 16787459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.